Pediatric acute-onset neuropsychiatric syndrome

What causes pediatric acute-onset neuropsychiatric syndrome (PANS)?

PANS is thought to have a variety of possible causes. More than 80% of cases are thought to result from an abnormal autoimmune or inflammatory response in the brain following some type of infection. When the infection is known to be strep, a person is diagnosed with P ediatric A utoimmune N europsychiatric D isorders A ssociated with S treptococcal Infections (PANDAS), a subtype of PANS. It is not yet known why some children get PANDAS after a strep infection while others do not. Other types of infections that may trigger symptoms of PANS include upper respiratory infections, influenza, chickenpox, mycoplasma, and Lyme disease.

Other possible causes of PANS include psychological trauma as well as underlying autoimmune, neurological, endocrine, or metabolic disorders. Examples include cerebral vasculitis (inflammation of blood vessels in the brain) and neuropsychiatric lupus. There are thought to be various non-infectious triggers that have not yet been identified. Additionally, future episodes of symptoms may be caused by triggers different from the trigger of the previous episodes. Of note, identifying a trigger is not required for a diagnosis of PANS.

Last updated on 05-01-20

How is pediatric acute-onset neuropsychiatric syndrome (PANS) diagnosed?

PANS is a clinical diagnosis, which means the diagnosis is based on the signs, symptoms and medical history rather than laboratory testing or imaging studies (although these are used to rule out other health problems). The current recommended criteria for a diagnosis of PANS include:

  • Sudden and severe onset of obsessive compulsive disorder or severely restricted food intake (appearing and worsening within 24-48 hours)
  • Simultaneous sudden and severe onset of at least two of the following additional neuropsychiatric symptoms:
    • Anxiety
    • Emotional lability (rapid changes in mood or emotion) and/or depression
    • Irritability, aggression, and/or severely oppositional behaviors
    • Behavioral (developmental) regression (loss of previously acquired skills or age-appropriate behavior)
    • Deterioration in school performance (e.g. symptoms of ADHD, memory deficits, or cognitive changes)
    • Sensory or motor abnormalities
    • Somatic signs and symptoms - various symptoms for which no medical explanation can be found, such as sleep disturbances, involuntary urination, or urinary frequency
  • Symptoms are not better explained by a known neurologic or medical disorder. The diagnosis of PANS should be made only when all other possible neurological or medical causes of symptoms are ruled out. This is a called a diagnosis of exclusion. Depending on symptoms present, examples of disorders to rule out may include obsessive-compulsive disorder, Tourette syndrome, Sydenham chorea, autoimmune encephalitis, neuropsychiatric lupus, central nervous system vasculitis, and other disorders.

Ruling out other conditions in order to diagnosis PANS may rely on:

  • A comprehensive medical history (including infection history) and physical exam. These should not focus only on identifying signs and symptoms of PANS, but on identifying and ruling out features of other disorders that cause similar symptoms.
  • Family history, with particular focus on neurologic diseases, mental health conditions, autoimmune and autoinflammatory diseases, immunodeficiency disorders, and frequent infections.
  • Psychiatric evaluation (individual PANS symptoms overlap with a variety of psychiatric disorders) and mental status exam.
  • Various blood tests, urinalysis, throat culture, and/or cerebrospinal fluid analysis.
  • Infectious disease evaluation (most cases of PANS are suspected to occur following an infection, particularly strep in those with the PANS subtype PANDAS).
  • Evaluation for autoimmune and autoinflammatory diseases (some of which can cause neuropsychiatric symptoms) and immunodeficiency.
  • Additional tests such as brain MRI, an electroencephalogram (EEG), sleep study (polysomnography), and/or swallowing study (for those with restricted food intake).

Detailed recommendations from the 2013 PANS Consensus Conference regarding evaluation and diagnosis can be viewed here.

Last updated on 05-01-20

How might pediatric acute-onset neuropsychiatric syndrome (PANS) be treated?

Treatment of pediatric acute-onset neuropsychiatric syndrome (PANS) depends on the specific symptoms, severity, and cause (if known) in each person. Initial treatment may depend on which symptoms most impair daily living and create the most distress. It is recommended that treatment begin as soon as the diagnosis is made. Treatment may involve the following, either alone or in combination:

  • Treating symptoms with psychiatric medications (when appropriate), psychotherapy (particularly cognitive behavioral therapy), and supportive interventions (such as school accommodations, family support, and maintaining nutrition and hydration needs with restricted food or fluid intake). Some interventions may take several weeks to begin helping and may require adjustments, as symptoms frequently change during the course of the condition. The experiences of healthcare professionals who treat PANS suggest that specific symptoms of PANS (such as anxiety and obsessive-compulsive symptoms) respond to the same medications used to treat these symptoms in people without PANS.
  • Treating underlying infections or sources of inflammation with antibiotics. An initial course of anti-strep antibiotics is recommended in all cases, even when there is not a documented infection. Some people with PANS have experienced complete and lasting remission of symptoms during treatment with antibiotics. Using antibiotics long-term to prevent infections (prophylaxis) may be recommended for children with PANDAS who have severe neuropsychiatric symptoms or recurrent strep-associated flares of symptoms.
  • Stabilizing the immune system with immunotherapy and/or anti-inflammatory therapies (in immune-related PANS). These therapies should be used only in cases where there is evidence of inflammation in the nervous system (neuroinflammation) or post-infectious autoimmunity (misdirected immune responses). Depending on symptoms and severity, therapy options may include nonsteroidal anti-inflammatory drugs, corticosteroids, and intravenous immune globulin (IVIG) or other nonsteroidal immunotherapies. Once started, immunotherapy should only continue if it is clear that symptoms are improving.

Treatment may be tapered down or stopped completely when symptoms resolve, but may be needed again if symptoms return (when treatment is stopped or at some time later). Many people with PANS will recover completely and discontinue some or all treatments. However, others will have ongoing symptoms that require continuous treatment. If not treated, PANS can lead to permanent debilitation.

In most cases, a child's primary care provider can effectively treat symptoms of PANS. Children with severe or life-threatening symptoms may need specialized treatment coordinated by a team of PANS specialists.

Detailed treatment recommendations for healthcare providers are available and can be accessed in our Learn More section under Selected Full-Text Journal Articles.

Last updated on 05-01-20

Where To Start

KidsHealth from Nemours

KidsHealth from Nemours has an information page on Pediatric acute-onset neuropsychiatric syndrome. Click on the link to access this resource.

Last updated on 04-27-20

Name: Child Mind Institute 445 Park Avenue
New York, NY, 10022,
Phone: (212) 308-3118 Url:
Name: PANS Research Consortium Url:
Name: PANDAS Physicians Network PPN 117 Eastbend Court
Mooresville, NC, 28117,
Toll Free: 855-347-4921 Fax : 1-800-641-7954 Email: Url:
Name: Pediatric Research and Advocacy Initiative PRAI P.O. BOX 2198
Chesterfield, VA, 23832,
Name: Alliance to Solve PANS & Immune-Related Encephalopathies ASPIRE Email: Url:

Connect with other users with Pediatric acute-onset neuropsychiatric syndrome on the RareGuru app

Do you have information about a disease, disorder, or syndrome? Want to suggest a symptom?
Please send suggestions to RareGuru!

The RareGuru disease database is regularly updated using data generously provided by GARD, the United States Genetic and Rare Disease Information Center.

People Using the App

Join the RareGuru Community

To connect, share, empower and heal today.

People Using the App